Israeli AI company partners with medical service to provide better cancer screening for NHS patients
Israel-based Ibex Medical Analytics uses artificial intelligence to identify discrepancies between diagnoses and test results for pathologists
While it’s true there is a supply and demand issue between pathologists and those needing pathology scans, Ibex places itself in an uncomfortable discussion around the idea of AI and its impact on healthcare professionals. For example, radiology is starting to see wide-spread disruption as patients begin to place more trust in machines than their human counterparts.
“I don’t see algorithms replacing pathologists,” Mossel claims. “They will work together in the same way that a pilot operates a jet plane — there’s auto-pilot to help you. It will become negligent to practice pathology without using the AI to help.”The inclusion of such technology is expected to reduce waiting times for patients and help identify potential misdiagnoses by overworked and understaffed pathologists in the UK. Ibex currently has 25 employees working out of its Tel Aviv office and has completed $13.6 million in Series A funding.